Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
AHRQ Home—Live Site | Archive Home | Site Map
Archive print banner

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to www.ahrq.gov for current information.

Database III: Genetic tests in development

Database of genetic tests in development

Table III-1: Test (by major types of cancer)

Return to Contents

Name Other Name Use Breast Prostate Lung Colorectal Pancreas Ovarian Esophagus Liver Lymphoma Leukemia Other
AFP-L3   Primary prevention               x      
Alpha Catenin Methylation marker Prognosis x                    
APC   Detection       x              
BAT-26 Microsatallite instability Detection       x              
Bladder cancer test   Diagnosis                     x
BladderChek NMP22 Diagnosis                     x
Breast Cancer Detection Nipple Aspirate Fluid Diagnosis x                    
Breast Cancer Outcome Prediction Test PIX2/TTF1 Diagnosis x                    
Cancer antigen 72-4 CA 72-4 Diagnosis                     x
CDK family Cyclin dependent kinase family Management     x                
CDKN24 Methylation marker Detection       x              
CDP/Cux   Diagnosis x                    
CellSearch Circulating tumor cells Diagnosis x                    
CeMines CellCorrect Lab   Diagnosis     x                
Chromosome 8q gain   Management           x          
c-Kit pharmDx Gleevec sensitivity test Management                     x
Colorectal cancer test   Diagnosis       x              
Colorectal gene panel 7 gene pharmacogenomic panel Management       x              
Colorectalert   Diagnosis       x              
Conversion Analysis Conversion Technology Diagnosis       x              
Cox-2 RNA Stool Detection       x              
cPSA Complexed PSA Management   x                  
CupPrint   Management                     x
Cyfra 21-1 Cytokeratin fragment 19 Diagnosis     x                
Cytokeratin 20 CK 20 Diagnosis       x              
CytoVision   Diagnosis                   x  
des-gamma carboxyprothrombin   Detection               x      
DNA methylation Oncomethylome Detection   x x     x         x
DNA methylation Second Code Diagnosis   x x x              
EEF1A2 Elongation factor Management x                    
EGFR Genzyme Detection     x     x         x
EGFR   Management     x                
EPCA   Diagnosis   x                  
eTag   Management x   x                
Genomic Test 3q, 7q, 16q, 17pter-q21 Diagnosis           x          
GOS Stool Detection       x              
GSTM1   Prediction     x                
GSTP1   Management   x                  
Her-1, Her-2, Her-3, Her-4   Diagnosis x                    
HLA-E   Prognosis                     x
HP1alpha   Management x                    
HPV test DNA with Pap Test Diagnosis                     x
HPV test Human papilloma virus cell swab Diagnosis                     x
IGF-II   Prediction                     x
IMI breast cancer test   Diagnosis x                    
Immunocyt/ uCyt   Diagnosis                     x
Iressa test   Management     x                
Key2   Diagnosis x                    
K-ras   Detection     x x              
Leukemia Affymetrix Chip   Diagnosis                   x  
Leukemia blood test MRD test Recurrence                   x  
Lung cancer test   Diagnosis     x                
Lung cancer test Electronic Nose Diagnosis     x                
LungAlert   Diagnosis     x                
Lysophopholipids LPA Detection           x          
M2-PK   Primary prevention       x              
MammaPrint   Management x                    
Matrix metalloproeinases MMP Detection           x          
Melanoma inhibiting antigen MIA Diagnosis                     x
Melastatin mRNA expression Management                     x
MESOMARK   Diagnosis                     x
MGMT Methylation marker Detection       x              
Microsatelitte Analysis Urine MicroSatellite Analysis Detection                     x
MLH1 Methylation marker Detection       x              
MN protein   Detection           x          
MSA   Management                     x
MSA analysis Microsatellite DNA Diagnosis                     x
NAF test   Diagnosis x                    
NMP179   Diagnosis                     x
NMP22 Matritek's Bladderchek test Detection                     x
NMP35   Diagnosis       x              
NMP48   Diagnosis   x                  
NMP66   Diagnosis x                    
OncoVue breast cancer risk test Tagit Primary prevention x                    
Ovacheck   Diagnosis           x          
Ovarian cancer biomarker test   Diagnosis           x          
Ovarian cancer test   Diagnosis           x          
Ovarian cancer test Ovarian Cancer Prognostic Profile Management           x          
Ovarian pap test   Detection           x          
p16, p15, p14 deletions   Management                   x x
p202   Management   x                  
p53 Affymetrix Chip   Diagnosis x                    
Prostate 63 AsymmetRx Management   x                  
Prostate biomarkers   Management   x                  
Prostate Cancer Blood Test ProteomeDx Diagnosis   x                  
Protein Profile test Lysophosphatidic acid (LPA) Recurrence           x          
PSA testing In office Diagnosis   x                  
PSMA Prostate specific membrane antigen Management   x                  
PSP94 Prostate secratory protein Diagnosis   x                  
PTEN tumor suppressor   Management   x                  
PyloriProbe DR70 Diagnosis       x              
Recaf Alpha feto protein receptor Diagnosis x x x x              
RhoC GTPase   Management x                    
S100   Diagnosis                     x
SELDI-TOF-MS Molecular profiling using SELDI Management x x x     x          
SurePath   Diagnosis                     x
Telomerase hTR, HTerRT Diagnosis                     x
TGF genes   Prognosis x                    
TUO test   Diagnosis                     x
uPM3 PCA3 assay Diagnosis   x                  
Urinary plasminogen activator suPAR Detection           x          
Urine test for cervical cancer   Diagnosis                     x
VEGF   Management       x              
WISP3   Management x                    

Return to Contents
Proceed to Next Section

The information on this page is archived and provided for reference purposes only.

 
AHRQ Advancing Excellence in Health Care